Food News and Research

RSS

Lucideon invests in an Agilent 7900 Quadrapole ICP-MS to extend its analysis techniques offerings

Lucideon, the international provider of materials development, testing and assurance, and formerly known as Ceram, is pleased to announce it has invested in the latest Agilent 7900 Quadrapole Inductively Coupled Plasma – Mass Spectrometry (ICP-MS).

From Lucideon 21 May 2014

AbbVie receives HUMIRA orphan drug designation from FDA for treatment of non-infectious uveitis

AbbVie announced today that the U.S. Food and Drug Administration has granted HUMIRA orphan drug designation for the treatment of non-infectious intermediate, posterior, or pan-uveitis, or chronic non-infectious anterior uveitis, a group of rare but serious inflammatory diseases of the eye.

21 May 2014

OSU's scientist leverages OSC systems to study 3-D model of ant anatomy

A recent study into the biomechanics of the necks of ants - a common insect that can amazingly lift objects many times heavier than its own body - might unlock one of nature's little mysteries and, quite possibly, open the door to advancements in robotic engineering.

21 May 2014

Edison Pharmaceuticals' EPI-743 granted orphan designation for Leigh syndrome in Japan

Edison Pharmaceuticals has announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has granted Orphan Designation to EPI-743 for the treatment of Leigh syndrome.

21 May 2014

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., has announced that the United States (U.S.) Food and Drug Administration (FDA) simultaneously approved a new biologic therapy, Entyvio™ (vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD).

21 May 2014

Aradigm receives QIDP designation for its inhaled antibiotic candidate, Pulmaquin

Aradigm Corporation (the "Company") today announced that the U.S. Food and Drug Administration (FDA) has designated the Company's lead inhaled antibiotic candidate, Pulmaquin®, as a Qualified Infectious Disease Product (QIDP).

20 May 2014

Consumer Reports reveals truth about sunscreen products

When it comes to sunscreen, SPF (sun protection factor) is the feature that influences consumers' purchasing decision most.

20 May 2014

Amsel Medical files 510(K) Pre-Marketing Notification with FDA for Amsel Occluder Device

Amsel Medical Corporation today announced that it has successfully completed filing of a Pre-Marketing Notification (510(k)) with the US Food and Drug Administration (FDA) for its Amsel Occluder Device.

20 May 2014

PAREXEL International launches Perceptive MyTrials Data-Driven Monitoring solution

PAREXEL International, a leading global biopharmaceutical services organization, today announced the launch of its Perceptive MyTrials® Data-Driven Monitoring solution.

From Parexel 20 May 2014

New study provides evidence that bacteria in gut may be linked to children with autism

Children with autism spectrum disorders (ASD) have significantly different concentrations of certain bacterial-produced chemicals, called metabolites, in their feces compared to children without ASD.

20 May 2014

Elotuzumab granted Breakthrough Therapy Designation for treatment of multiple myeloma

Bristol-Myers Squibb Company and AbbVie today announced that the U.S. Food and Drug Administration (FDA) has granted elotuzumab, an investigational humanized monoclonal antibody, Breakthrough Therapy Designation for use in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma in patients who have received one or more prior therapies.

20 May 2014

TSRI chemists develop correct structure of highly promising anticancer compound

Chemists at The Scripps Research Institute (TSRI) have determined the correct structure of a highly promising anticancer compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials in cancer patients.

20 May 2014

Researchers identify drugs to slow progression of idiopathic pulmonary fibrosis

Researchers in separate clinical trials found two drugs slow the progression of idiopathic pulmonary fibrosis, a fatal lung disease with no effective treatment or cure, and for which there is currently no therapy approved by the Food and Drug Administration.

19 May 2014

Shire intends to submit NDA for lifitegrast to treat dry eye disease

Following a May 15, 2014, meeting with the U.S. Food and Drug Administration (FDA), Shire plc, the global specialty biopharmaceutical company, announces today that it intends to submit a New Drug Application for lifitegrast as a treatment for the signs and symptoms of dry eye disease in adults in the first-quarter 2015, as we complete remaining chemistry and manufacturing work.

19 May 2014

UCMC's new program supports families with sick, premature babies hospitalized immediately after birth

A new program to support families with sick and premature babies hospitalized immediately after birth was unveiled at University of Cincinnati Medical Center (UCMC) today.

19 May 2014

Study finds association between sleep and obesity in young children

One of the most comprehensive studies of the potential link between reduced sleep and childhood obesity finds compelling evidence that children who consistently received less than the recommended hours of sleep during infancy and early childhood had increases in both obesity and in adiposity or overall body fat at age 7.

19 May 2014

Healthy eating in schools requires workforce education according to research produced by Sheffield Hallam University

The whole school workforce should be educated in food, nutrition and healthy eating, if the government's School Food Plan is to be a success, according to research produced by Sheffield Hallam University's new Institute of Education.

From Sheffield Hallam University 16 May 2014

First Edition: May 16, 2014

Today's headlines include reports about the Indiana governor's alternative plan to expand Medicaid. Kaiser Health News staff writer Sarah Varney, working in collaboration with PBS Newshour, reports: "Men and women involved in the criminal justice system are more likely to be sicker than the general population, with higher rates of diabetes, hypertension, depression, mood disorders and alcohol and drug addiction.

16 May 2014

TOLMAR Pharmaceuticals holds exclusive distribution rights to ELIGARD in the U.S. and Puerto Rico

TOLMAR Pharmaceuticals, Inc., focused on specialty pharmaceutical products, today announced that, effective May 8, 2014, the company holds exclusive distribution rights to ELIGARD® (leuprolide acetate for injectable suspension) in the U.S. and Puerto Rico.

16 May 2014

State highlights: 700 nurses needed for health care help in Calif. county; Missouri abortion wait period; nursing home funding in Maine

A selection of health policy stories from California, Missouri, Maine, Michigan, North Carolina, Texas and Georgia.

16 May 2014

Food News and Research

Lucideon invests in an Agilent 7900 Quadrapole ICP-MS to extend its analysis techniques offerings

AbbVie receives HUMIRA orphan drug designation from FDA for treatment of non-infectious uveitis

OSU's scientist leverages OSC systems to study 3-D model of ant anatomy

Edison Pharmaceuticals' EPI-743 granted orphan designation for Leigh syndrome in Japan

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Aradigm receives QIDP designation for its inhaled antibiotic candidate, Pulmaquin

Consumer Reports reveals truth about sunscreen products

Amsel Medical files 510(K) Pre-Marketing Notification with FDA for Amsel Occluder Device

PAREXEL International launches Perceptive MyTrials Data-Driven Monitoring solution

New study provides evidence that bacteria in gut may be linked to children with autism

Elotuzumab granted Breakthrough Therapy Designation for treatment of multiple myeloma

TSRI chemists develop correct structure of highly promising anticancer compound

Researchers identify drugs to slow progression of idiopathic pulmonary fibrosis

Shire intends to submit NDA for lifitegrast to treat dry eye disease

UCMC's new program supports families with sick, premature babies hospitalized immediately after birth

Study finds association between sleep and obesity in young children

Healthy eating in schools requires workforce education according to research produced by Sheffield Hallam University

First Edition: May 16, 2014

TOLMAR Pharmaceuticals holds exclusive distribution rights to ELIGARD in the U.S. and Puerto Rico

State highlights: 700 nurses needed for health care help in Calif. county; Missouri abortion wait period; nursing home funding in Maine

Enhancing confidence in chemical ionization spectrometry data eBook

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Latest News